Literature DB >> 33412761

Updated confidence intervals for the COVID-19 antibody retention rate in the Korean population.

Md Kamruzzaman1, Catherine Apio2, Taesung Park1,2.   

Abstract

With the ongoing rise of coronavirus disease 2019 (COVID-19) pandemic across the globe, interests in COVID-19 antibody testing, also known as a serology test has grown, as a way to measure how far the infection has spread in the population and to identify individuals who may be immune. Recently, many countries reported their population based antibody titer study results. South Korea recently reported their third antibody formation rate, where it divided the study between the general population and the young male youths in their early twenties. As previously stated, these simple point estimates may be misinterpreted without proper estimation of standard error and confidence intervals. In this article, we provide an updated 95% confidence intervals for COVID-19 antibody formation rate for the Korean population using asymptotic, exact and Bayesian statistical estimation methods. As before, we found that the Wald method gives the narrowest interval among all asymptotic methods whereas mid p-value gives the narrowest among all exact methods and Jeffrey's method gives the narrowest from Bayesian method. The most conservative 95% confidence interval estimation shows that as of 00:00 November 23, 2020, at least 69,524 people were infected but not confirmed. It also shows that more positive cases were found among the young male in their twenties (0.22%), three times that of the general public (0.051%). This thereby calls for the quarantine authorities' need to strengthen quarantine managements for the early twenties in order to find the hidden infected people in the population.

Entities:  

Keywords:  COVID-19 antibody; confidence interval; retention rate

Year:  2020        PMID: 33412761      PMCID: PMC7808864          DOI: 10.5808/GI.2020.18.4.e45

Source DB:  PubMed          Journal:  Genomics Inform        ISSN: 1598-866X


  3 in total

1.  Testing for SARS-CoV-2 antibodies.

Authors:  Jessica Watson; Alex Richter; Jonathan Deeks
Journal:  BMJ       Date:  2020-09-08

2.  COVID-19 antibodies on trial.

Authors:  Laura DeFrancesco
Journal:  Nat Biotechnol       Date:  2020-11       Impact factor: 68.164

  3 in total
  2 in total

1.  Geographic spread of COVID-19 and local economies: Heterogeneous effects by establishment size and industry.

Authors:  Jun Sung Kim; Taehoon Kim
Journal:  J Reg Sci       Date:  2021-09-23

2.  Estimation of Undetected Asymptomatic COVID-19 Cases in South Korea Using a Probabilistic Model.

Authors:  Chanhee Lee; Catherine Apio; Taesung Park
Journal:  Int J Environ Res Public Health       Date:  2021-05-06       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.